Financial Information Show all 2023 Q1 Syndax Pharmaceuticals Reports First Quarter 2023 Financial Results and Provides Clinical and Business Update Form 10-Q Proxy Statements There are no SEC filings available. Form 10-K Filing date View 03.14.17 View HTML 0001193125-17-081863.pdf 0001193125-17-081863.xls EX-101.INS - XBRL INSTANCE DOCUMENT Form 10-Q Filing date View 05.16.16 View HTML 0001193125-16-591861.pdf 0001193125-16-591861.xls EX-101.INS - XBRL INSTANCE DOCUMENT 08.15.16 View HTML 0001193125-16-681546.pdf 0001193125-16-681546.xls EX-101.INS - XBRL INSTANCE DOCUMENT
